Clinical Trial Update: 8- Versus 12-week of Sofosbuvir-ravidasvir Treatment of Chronic Hepatitis C [Phase 2, Phase 3]

View source ↗

Summary

Completed Phase 2/3 clinical trial comparing 8-week versus 12-week regimens of sofosbuvir-ravidasvir for chronic Hepatitis C. The snippet does not provide resul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Ravidasvir (ravidasvir)
• Sofosbuvir (sofosbuvir)

Snippet

Sponsor: Muhammad Radzi Abu Hassan | Conditions: Hepatitis C | Phase 2, Phase 3 | Status: COMPLETED